Latest news
Loading news…
Cangene
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Baltimore, Maryland, United States Founded 1984 1001-5000 employees For Profit
Cangene is a fully integrated developer and manufacturer of immune therapeutics. Our first drug, WinRho® SDF, has been commercially
Cangene was acquired by Emergent BioSolutions in 2013 for $222M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 1
- IT spend
- $9M
Company Info
- Founded
- 1984
- Employees
- 1001-5000
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- News articles
- 3
- HQ
- Baltimore, Maryland, United States
- Region
- Greater Baltimore-Maryland Area, East Coast, Southern US
- Exit date
- Dec 11, 2013
Signals & Scores
- Heat score
- Medium
- Trend (7d)
- 6.1
- Trend (30d)
- 7.3
- Trend (90d)
- 6.6
Acquisitions by Cangene
Loading columns…
0 of 0Show
Page 1 / 1
1
professional contacts at Cangene
Contact execs at Cangene →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Cangene
Loading news…
FAQs about Cangene
People who checked this page also checked these
Sectors Cangene invests & acquires in
Browse the full Acquirezy directory.